Increasing investments in pulmonary drug delivery technologies are driving innovation in inhalation-based treatments and drug formulations. The Pulmonary Drug Delivery Systems Market size is expected to reach US$ 79.3 Billion by 2033 from US$ 58.4 Billion in 2025. The market is estimated to record a CAGR of 3.90% from 2026 to 2033. The pulmonary drug delivery systems market is experiencing...